K-Shaped AI Will Not Be Evenly Distributed
I've worked in two very different health systems. During my surgical training at Stanford, the EHR had real-time clinical decision support, imaging AI was being piloted in radiology, and the analytics team was larger than the surgical residents' lounge. Later, consulting for a community hospital system in the Central Valley, I watched a solo hospitalist manage a 22-patient census with a fax machine, a pager, and an EHR that crashed every time someone ran a report. Same state. Same year. Completely different centuries of operational infrastructure.
That gap is not anecdotal. It is now quantified. An ONC data brief tracking hospital predictive AI adoption found that usage grew from 66% to 71% between 2023 and 2024, but urban hospitals adopted at 77-81% versus just 48-56% for rural hospitals. Critical Access Hospitals, the smallest and most remote facilities, lagged further at 46-50%. A national study across 3,143 U.S. counties published on medRxiv found that only 65.8% of Americans lived within 30 minutes of AI-enabled care, and the Gini coefficient for AI access actually increased from 0.739 to 0.767, meaning expansion disproportionately benefited areas that were already well-served.
AI in healthcare is advancing in a K-shaped pattern. Some health systems are moving sharply upward with better tools, more capital, stronger data infrastructure, and faster regulatory capacity. Others are stagnating or falling further behind. That is not a speculative edge case. It is the documented default.
From my vantage point as a physician-executive who has practiced in both arms of the K, this matters because AI is not merely a software layer. It is becoming an operating advantage. The health systems that can deploy it well will gain leverage across scheduling, documentation, revenue cycle management, triage, population health, and clinical decision support. Systems that cannot will keep paying the hidden tax of administrative overload, clinician burnout, and inefficient resource allocation. For context on the clinical lens behind this analysis, see my background and editorial work at sinabarimd.com.
What a K-Shaped AI Takeoff Means in Practice
The “up” side of the K
The upward arm of the K belongs to health systems that already have the ingredients for adoption: robust EHR data, cloud capacity, legal and compliance support, capital for implementation, and leadership willing to redesign workflows rather than simply purchase a tool. These organizations can pilot models, retrain staff, integrate guardrails, and iterate. They can absorb early inefficiency in exchange for later gains.
These systems are also more likely to sit near research universities, major payer networks, and venture ecosystems. That proximity matters. It accelerates access to talent, partnerships, and capital. In the United States, large academic medical centers and integrated delivery networks are especially well positioned. Globally, wealthy private systems and national health services with strong digital infrastructure may also capture the first wave of benefit.
The “down” side of the K
The downward arm includes rural hospitals, safety-net institutions, underfunded public systems, and health ministries operating with limited digital infrastructure. These organizations face the same workforce shortages and patient complexity as everyone else, but with less margin for experimentation. For them, AI may arrive as a vendor pitch rather than a durable capability.
The danger is not just delayed adoption. It is asymmetric dependence. Under-resourced systems may become consumers of tools designed elsewhere, priced beyond reach, trained on populations unlike their own, and optimized for metrics that do not reflect their realities. If AI lowers costs only for those already well resourced, it can entrench a two-tier healthcare economy with algorithmic varnish.
How AI Could Widen Health Resource Inequality
Efficiency gains can compound existing advantage
AI usually enters medicine through the tasks that are easiest to automate: documentation, inbox management, coding support, prior authorization, imaging triage, and operational forecasting. The ONC data shows the fastest-growing hospital AI applications between 2023 and 2024 were billing (36% to 61% adoption) and scheduling (51% to 67%). Those are not trivial tasks. They are the glue that determines whether clinicians spend their time practicing medicine or processing friction.
I've lived the difference. At a well-resourced system, I could close a clinic note in under two minutes with AI-assisted documentation. At the community hospital, the same note took twelve minutes of manual point-and-click charting. Multiply that by 18 patients a day, 5 days a week, and you get roughly 15 hours per month of physician time consumed by documentation alone. That's not a convenience gap. That's an FTE gap. The system with AI can see more patients, or the same number of patients with less burnout. The system without AI loses a physician-equivalent every two months to administrative overhead.
That compounding effect is what makes the issue structural. A system that deploys AI to cut administrative drag can absorb more patients, recruit more clinicians, and reinvest savings into service lines. A system that cannot deploy AI continues hemorrhaging staff and capacity. The Gini coefficient for AI access is widening, not narrowing. Expansion is reaching the well-served first.
Data quality and model performance can mirror inequity
Healthcare AI is only as good as the data it learns from. The World Health Organization’s guidance on ethics and governance of AI for health emphasizes the risks of biased data, weak oversight, and unequal access to benefits. Those warnings matter because underrepresented populations are often the least likely to be reflected in development datasets and the most likely to experience harm when a model is deployed without adaptation.
In practical terms, the systems with the best data will see the best performance first. The systems with messy, incomplete, or fragmented data may experience worse outputs and slower returns, reinforcing the perception that AI “works” only where it was already easier to implement. That is an implementation problem, but also a political one. Infrastructure is destiny when scale matters.
Global disparities may deepen faster than domestic ones
Internationally, the risks are even sharper. Wealthy countries will be able to negotiate enterprise contracts, host local compute, maintain compliant data pipelines, and train clinicians at scale. Lower-income countries may face imported systems, dependency on external cloud providers, and limited leverage over pricing or model behavior. The result could be a digital version of the old medical divide: the best tools available where systems already have the least constraint, while the largest disease burdens remain in settings least able to pay for innovation.
That is especially concerning because health systems in low-resource settings often need efficiency gains more urgently than rich systems do. Yet urgency does not translate into adoption when basic digital infrastructure is missing. The market will not fix that on its own.
Which Health Systems Benefit Most?
Systems with scale, capital, and clean workflow design
Large systems benefit first because they can amortize implementation costs over many encounters. They also have the institutional capacity to redesign workflows, measure outcomes, and manage change. If a health system already has mature analytics teams and standardized documentation, AI can be integrated into a larger operational strategy rather than deployed as a shiny accessory.
Health systems with strong payer integration may also gain more quickly because they can align AI use with utilization management, risk prediction, and care coordination. That can be good or bad depending on governance. Used well, it can improve preventive care and close gaps. Used badly, it can become another mechanism for denial or cost shifting.
Organizations that treat AI as governance, not gadgetry
The most successful adopters will not be the ones that buy the most tools. They will be the ones that create rules for procurement, validation, monitoring, escalation, and clinician override. AI in healthcare should be judged like any other clinical infrastructure: by whether it improves outcomes, reduces inequity, and preserves professional judgment. The systems most likely to benefit are the ones willing to say no to tools that do not meet those standards.
That is the lesson I keep returning to from my work across both sides of the K. The community hospital where I consulted eventually purchased an AI documentation tool. It sat unused for six months because no one had redesigned the clinic workflow to accommodate it, no one had trained the physicians, and no one had assigned governance responsibility for reviewing the outputs. Technology does not create maturity. Leadership does. And the leadership gap between well-resourced and under-resourced systems is at least as wide as the technology gap.
What Governance Frameworks Could Prevent AI-Driven Disparities?
Fair access should be a policy objective, not a side effect
Equitable AI deployment begins with the idea that access itself should be governed. If the only institutions that can afford high-quality AI are elite institutions, disparity is not a bug; it is the business model. Public payers, regulators, and hospital leaders should treat fair access to clinically useful AI as part of health infrastructure, much like broadband, quality reporting, or drug availability.
Procurement standards, audits, and transparency
Governance frameworks should require transparency about training data, validation populations, performance stratified by subgroup, and the intended use case. That does not mean every model must be open source. It does mean health systems should know what they are buying and whether it works for their patients. Independent audits, post-deployment monitoring, and mandatory incident reporting can reduce the chance that an inequitable system quietly scales.
As the NIST AI Risk Management Framework makes clear, risk in AI is not confined to accuracy. It includes validity, safety, security, resilience, accountability, and transparency. Healthcare should adopt that broader view. An elegant model that fails in the clinic is not innovation. It is negligence with a dashboard.
Shared infrastructure and public options
One of the strongest policy responses would be public or consortium-based AI infrastructure for healthcare. Shared models, shared evaluation platforms, and public compute subsidies could prevent every hospital from reinventing the wheel at a different cost point. For under-resourced systems, consortium procurement may be the difference between participation and exclusion.
Governments could also fund open clinical datasets, neutral evaluation labs, and implementation support for safety-net providers. If AI is going to become essential healthcare infrastructure, then some of it should be built like infrastructure: publicly governed, access-oriented, and durable.
Human oversight must remain central
No governance model is credible if it treats clinicians as passive recipients of model outputs. The goal is not to replace physician judgment with statistical automation. The goal is to reduce noise, surface risk, and expand capacity while preserving accountability. Clinicians should retain the authority to override AI, and institutions should measure when and why overrides happen. That is how systems learn.
The future profession will not be defined by whether AI exists in medicine. It will be defined by who controls it, who benefits from it, and who is asked to absorb its failures.
Equitable AI Deployment Looks Less Glamorous Than People Think
Equity does not mean every health system gets the same tool at the same time. It means the people with the greatest need are not automatically the last to benefit. In medicine, equitable deployment would look like affordable access for safety-net institutions, validation across diverse populations, local adaptation, clinician training, and funding models that do not punish low-margin systems for adopting high-value tools.
It would also mean resisting a narrow definition of success. If AI helps a wealthy health system shave minutes off documentation but leaves rural clinics unable to triage patients safely, the aggregate gain may hide a moral loss. The point of healthcare is not to maximize technological elegance. It is to improve care where care is hardest to deliver.
That is why the K-shaped takeoff matters. It is a warning about path dependence. The faster AI moves, the easier it will be to mistake adoption for progress. The harder task is to ensure that the next phase of medicine does not simply reward the systems already built to win.
I think about the hospitalist in the Central Valley regularly. He was a better diagnostician than most physicians I trained with at Stanford. His patients were sicker, his resources thinner, his documentation burden heavier. He would have benefited from AI more than any of us. He was the last in line to receive it. That ordering, unless deliberately interrupted, is the K-shape. And once the arms of the K diverge far enough, they become self-reinforcing. The systems with AI attract the physicians who want to practice with AI. The systems without it lose them. The gap stops being about technology and becomes about workforce. That's when it gets permanent.
FAQ
What is a K-shaped AI takeoff in healthcare?
It is a pattern in which AI adoption accelerates for well-funded, digitally mature health systems while under-resourced systems lag behind, creating diverging trajectories of capacity, efficiency, and patient access.
How could AI widen health resource inequality?
AI can widen inequality by compounding the advantages of systems that already have capital, data infrastructure, and implementation teams, while leaving safety-net and low-resource systems with weaker tools, higher costs, and slower workflow improvement.
What governance frameworks can prevent AI-driven health disparities?
Effective frameworks include procurement standards, subgroup performance audits, post-deployment monitoring, transparency requirements, public infrastructure support, and policies that make equitable access to high-value tools a health system priority.
Which health systems benefit most from healthcare AI adoption?
Systems with scale, capital, clean data, standardized workflows, and leadership capable of redesigning operations usually benefit first because they can absorb implementation costs and convert efficiency gains into expanded capacity.
What does equitable AI deployment look like in medicine?
Equitable deployment means affordable access for underserved systems, validation across diverse populations, local adaptation, clinician oversight, and funding models that help low-margin institutions use AI without being left behind.